• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    UFP Technologies Acquires DAS Medical

    12/23/21 9:00:00 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care
    Get the next $UFPT alert in real time by email

    NEWBURYPORT, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of DAS Medical, Inc. Founded in 2010 and headquartered in Atlanta, Georgia, with manufacturing in the Dominican Republic, DAS is a medical device contract manufacturer specializing in the design, development and production of single-use surgical equipment covers, robotic draping systems and fluid control pouches.

    "Adding DAS Medical to the UFP MedTech portfolio is another important step in our growth strategy," said R. Jeffrey Bailly, chairman, CEO, and president of UFP Technologies. "DAS's expertise in thin film converting and near-shore manufacturing is a perfect complement to our best-in-class RF welding technologies. Along with our new facility in Tijuana, Mexico, this adds another low-cost manufacturing option for our customers."

    "We are also excited to be partnering with the DAS management team," Bailly said. "We are strategically and culturally aligned, with a laser focus on creating value for customers in similar growth segments. We currently share key strategic customers, and can now create more value by offering a full suite of services for single-use, flexible material-based medical devices."

    According to Daniel Lee, DAS's president and CEO, "Joining forces with UFP's MedTech team is a fantastic strategic fit. We both have expertise in creating differentiated solutions leveraging expertise in medical film converting for critical single-use applications. With access to UFP's sales engine, development engineers and growing technology portfolio, we will be able to accelerate the growth of our proven low-cost manufacturing platform in the Dominican Republic."

    About UFP Technologies, Inc.

    UFP Technologies is an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market. Utilizing highly specialized foams, films, and plastics, we convert raw materials through laminating, molding, radio frequency welding, and fabricating techniques. We are diversified by also providing highly engineered solutions to customers in the aerospace & defense, automotive, consumer, electronics, and industrial markets.

    Forward Looking Statements

    This press release contains statements relating to expected financial performance and/or future business prospects, events and plans that are forward-looking statements. Such statements include, but are not limited to: the anticipated effects on us of acquiring DAS Medical, Inc.; anticipated trends in the different markets in which we compete and expectations regarding customer demand; expectations regarding our business opportunities; and statements about our growth potential and strategies for growth. Investors are cautioned that such forward-looking statements involve risks and uncertainties that could adversely affect our business and prospects, and otherwise cause actual results to differ materially from those anticipated by such forward-looking statements, as well as other risks and uncertainties that are detailed in the documents we file with the SEC. Accordingly, actual results may differ materially. Readers are referred to the documents we file with the SEC, specifically the last report on Form 10-K. The forward-looking statements contained herein speak only of our expectations as of the date of this press release. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in our expectations or any change in events, conditions, or circumstances on which any such statement is based.

    Contact: Ron Lataille

    978-234-0926, [email protected]



    Primary Logo

    Get the next $UFPT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UFPT

    DatePrice TargetRatingAnalyst
    3/28/2025Mkt Perform
    Raymond James
    7/17/2024$344.00 → $392.00Buy
    Lake Street
    3/20/2024Market Outperform
    CJS Securities
    2/6/2024Sector Weight
    KeyBanc Capital Markets
    12/21/2022$124.00Buy
    Lake Street
    6/22/2022$110.00Buy
    Lake Street
    11/19/2021$81.00Buy
    Colliers Securities
    More analyst ratings

    $UFPT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UFP Technologies Announces Record Q2 Results

    NEWBURYPORT, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its second quarter ended June 30, 2025, compared to net income of $13.6 million or $1.75 per diluted common share outstanding for the same quarter in 2024. Adjusted earnings per diluted common share outstanding grew 27% to $2.50. Sales for the second quarter were $151.2 million compared to sales of $110.2 million in the second quarter of 2024. Net income for the six-month period ended June

    8/4/25 4:15:31 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    UFP Technologies to Report Second Quarter 2025 Financial Results on August 4, 2025

    NEWBURYPORT, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced the Company plans to report financial results for the second quarter ended June 30, 2025 on August 4, 2025 after the market close. The Company will hold a conference call to discuss results the following day, August 5th, at 8:30 AM Eastern time. Conference Call Information:Date: Tuesday, August 5, 2025Time: 8:30 AM Eastern TimeParticipants may join the call using the following dial-in numbers: Toll-Free: 1-888-243-4451International: 1-412-542-4135 A live

    7/29/25 4:15:41 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    Trout Capital Advisors Serves as Exclusive Financial Advisor to Universal Plastics & Engineering Company in Sale to UFP Technologies

    LANCASTER, Pa., July 29, 2025 /PRNewswire/ -- Trout Capital Advisors, LLC ("TCA"), a leading lower-middle market investment banking firm, is pleased to announce it served as the exclusive financial advisor to Universal Plastics & Engineering Company, Inc. ("UNIPEC") in its sale to UFP Technologies, Inc. (NASDAQ:UFPT), a designer and manufacturer of innovative custom-engineered components, products, and solutions for the medical market. Headquartered in Rockville, Maryland, UNIPEC develops and manufactures precision thermoformed and heat-sealed polymer components used primarily for shielding batteries in Class III implantable medical devices. UNIPEC's capabilities and strong customer relatio

    7/29/25 10:05:00 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    $UFPT
    SEC Filings

    View All

    SEC Form 10-Q filed by UFP Technologies Inc.

    10-Q - UFP TECHNOLOGIES INC (0000914156) (Filer)

    8/11/25 8:31:47 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    UFP Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

    8/5/25 8:15:35 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    UFP Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

    7/17/25 10:22:29 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    $UFPT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Croteau Daniel C exercised 1,318 shares at a strike of $22.36, increasing direct ownership by 55% to 3,728 units (SEC Form 4)

    4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

    8/14/25 5:40:39 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    Director Hassett Joseph was granted 625 shares, increasing direct ownership by 53% to 1,800 units (SEC Form 4)

    4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

    6/6/25 2:52:16 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    Director Hudson Symeria was granted 625 shares, increasing direct ownership by 118% to 1,153 units (SEC Form 4)

    4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

    6/6/25 2:50:51 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    $UFPT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Raymond James initiated coverage on UFP Technologies

    Raymond James initiated coverage of UFP Technologies with a rating of Mkt Perform

    3/28/25 8:21:18 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    Lake Street reiterated coverage on UFP Technologies with a new price target

    Lake Street reiterated coverage of UFP Technologies with a rating of Buy and set a new price target of $392.00 from $344.00 previously

    7/17/24 8:57:19 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    CJS Securities initiated coverage on UFP Technologies

    CJS Securities initiated coverage of UFP Technologies with a rating of Market Outperform

    3/20/24 9:43:53 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    $UFPT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Lataille Ronald J bought $91,636 worth of shares (400 units at $229.09), increasing direct ownership by 3% to 15,031 units (SEC Form 4)

    4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

    2/27/25 3:57:17 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Lataille Ronald J

    4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

    11/13/23 11:09:49 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    Rock Mitchell bought $27,522 worth of shares (198 units at $139.00), increasing direct ownership by 0.74% to 27,086 units (SEC Form 4)

    4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

    11/9/23 5:21:17 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    $UFPT
    Leadership Updates

    Live Leadership Updates

    View All

    UFP Technologies Acquires AQF Medical

    NEWBURYPORT, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AQF Limited ("AQF Medical"). Headquartered in Navan, Ireland with additional joint venture operations in Singapore, AQF Medical develops and manufactures custom-engineered foam and thermoplastic components used in a wide range of medical devices and packaging. "We are excited about the addition of AQF Medical, our fourth acquisition in the past few months," said R. Jeffrey Bailly, Chairman and CEO of UFP Technologies.

    8/26/24 9:00:00 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    UFP Technologies Acquires Marble Medical

    NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Marble Medical. Founded in 1988 and headquartered in Tallahassee, FL, Marble Medical develops and manufactures adhesive based medical components and single-use devices. "Adding Marble Medical's adhesives expertise is a great complement to our surgical robot drapes and stick to skin device platforms," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Marble Medical is a 3M Preferred Converter, and along wi

    7/16/24 4:05:00 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    Chimerix Appoints Marc D. Kozin to Board of Directors

    DURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced the appointment of Marc D. Kozin as the newest member of the Company's Board of Directors. In addition, Patrick Machado has announced his retirement from the Chimerix Board effective at the Company's 2024 Annual Meeting of Stockholders in June, after ten years of service. "We are pleased to welcome Marc to the Board of Directors. Marc's strategic insights and leadership will undoubtedly contribute to the continued growth and success of Chimerix as we wo

    3/21/24 7:00:00 AM ET
    $CMRX
    $UFPT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    $UFPT
    Financials

    Live finance-specific insights

    View All

    UFP Technologies Announces Record Q2 Results

    NEWBURYPORT, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its second quarter ended June 30, 2025, compared to net income of $13.6 million or $1.75 per diluted common share outstanding for the same quarter in 2024. Adjusted earnings per diluted common share outstanding grew 27% to $2.50. Sales for the second quarter were $151.2 million compared to sales of $110.2 million in the second quarter of 2024. Net income for the six-month period ended June

    8/4/25 4:15:31 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    UFP Technologies to Report Second Quarter 2025 Financial Results on August 4, 2025

    NEWBURYPORT, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced the Company plans to report financial results for the second quarter ended June 30, 2025 on August 4, 2025 after the market close. The Company will hold a conference call to discuss results the following day, August 5th, at 8:30 AM Eastern time. Conference Call Information:Date: Tuesday, August 5, 2025Time: 8:30 AM Eastern TimeParticipants may join the call using the following dial-in numbers: Toll-Free: 1-888-243-4451International: 1-412-542-4135 A live

    7/29/25 4:15:41 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    UFP Technologies Acquires UNIPEC and TPI to Expand Film and Thermoplastic Molding Capabilities

    NEWBURYPORT, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisitions of Universal Plastics & Engineering Company, Inc. ("UNIPEC") and Techno Plastics Industries, Inc. ("TPI"). These transactions further expand UFP's capabilities in tight tolerance film components and thermoplastic molding for the medical device market. UNIPEC, headquartered in Rockville, Maryland, develops and manufactures precision thermoformed and heat-sealed polymer components used primarily for shielding batteries in C

    7/17/25 9:00:00 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    $UFPT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by UFP Technologies Inc.

    SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)

    11/13/24 9:58:23 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by UFP Technologies Inc. (Amendment)

    SC 13G/A - UFP TECHNOLOGIES INC (0000914156) (Subject)

    3/8/24 3:02:25 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by UFP Technologies Inc.

    SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)

    2/13/24 5:16:09 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care